Scientific Advisory Committee Co-Chairs

  • Timothy Yap, M.B.B.S, Ph.D.

    Professor of Investigational Cancer Therapeutics & Thoracic/Head & Neck Medical Oncology, Vice President & Head of Clinical Development for Therapeutics Discovery Division, MD Anderson

  • Timothy Heffernan, Ph.D.

    Vice President & Head of Therapeutics Discovery Division, MD Anderson

Scientific Advisory Committee

  • Christopher Flowers, MD

    Christopher Flowers, MD

    Division Head of Cancer Medicine, and Chair of Lymphoma/Myeloma, MD Anderson

  • Lauren Averett Byers, M.D.

    Professor of Thoracic-Head & Neck Medical Oncology, MD Anderson

  • Michael Curran, Ph.D

    Professor of Immunology, MD Anderson

  • Hussein Tawbi, M.D., Ph.D.

    Professor of Melanoma Medical Oncology, MD Anderson

  • Navel G. Daver, M.D.

    Professor of Leukemia, MD Anderson

  • Amir Anthony Jazaeri, M.D.

    Professor of Gynecologic Oncology and Reproductive Medicine, MD Anderson

  • Marc Matrana, M.D.

    Ochsner MD Anderson Cancer Center’s Medical Director of Precision Cancer Therapies Research Program

  • David S. Hong, M.D.

    Professor of Investigational Therapeutics, MD Anderson

  • Scott Kopetz, M.D. Ph.D, FACP

    Associate Vice President for Translational Integration, Professor of Gastrointestinal Medical Oncology at MD Anderson

  • Jason Bock

    CTMC Co-Founder and CEO

  • Emily Barnhill

    Vice President, Strategic Industry Ventures, MD Anderson

  • Shara Avis Pecoraro

    Strategic Industry Ventures, MD Anderson

  • Cassandra Moyer

    Program Manager, Strategic Industry Ventures, MD Anderson